Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,700.4
88.8 (3.40%)

 

  • STI Straits Times Index
    2,700.4
    88.8 (3.40%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,538.5
    30.8 (2.05%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,325.6
    329.7 (1.37%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,923.4
    2.0 (0.07%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,613.8
    288.1 (1.29%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,941.0
    93.5 (1.93%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,748.2M
  • Value: 2,480.4M
  • Rise: 237
  • Fall: 143
  • Unch: 428

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.192-0.003
ComfortDelGro1.610+0.120
Singtel2.570+0.030
Mapletree Log Tr1.950-0.060
ThaiBev0.715+0.035
ESR-REIT0.395-0.020
CapitaMall Trust2.140+0.010
Golden Agri-Res0.160+0.006
Secura0.093-0.007
AusGroup0.029+0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,608.4 +56.3
HSI 24,325.6 +329.7
HSCEI 9,967.5 +91.3
Jakarta 4,941.0 +93.5
Nikkei 225 22,613.8 +288.1
SSE Comp 2,923.4 +2.0
Shanghai A 3,064.3 +2.1
Shanghai B 205.3 -2.4
KOSPI 2,147.0 +59.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

DORSAVI LTD DORSAVI
Updated on 03 Jun 2020 (End of trading day)
Last (AUD): 0.017 Change: - High: 0.017 Remarks: -
Change (%): - Low: 0.017
Open 0.017 Yesterday's Close 0.017
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) - Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.01737 Trailing EPS (AUD) e -0.03444 NAV (AUD) b 0.0065
PE a - Trailing PE f - Price / NAV b 2.6154
Dividend (AUD) d - Cash In Hand (AUD) g 0.0111 Issued & Paid-up Shares c 231,428,000
Dividend Yield (%) d - Price / Cash In Hand g 1.532 Treasury Shares h -
Beta - 75 Daysi -0.231 R-Squared - 75 Days(%)i 0.01 Market Cap (M) 3.934
Beta - 500 Daysi 0.258 R-Squared - 500 Days (%)i 0.12 Enterprise Value (M) 2.769
Piotroski F Score 0 Exchange Code DVL Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 138.46 Free Float (%) 96.2
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 04 Feb 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 11 Mar 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference DORSAVI LTD ASX 3.934 - - 2.6154 -
Industry Medical Specialties ASX 1,536.708 61.745 60.233 17.3388 1.083
Local Peer FISHER & PAYKEL HEALTHCARE CORP ASX 15,664.448 80.204 71.088 18.3402 0.935
Local Peer COCHLEAR LTD ASX 12,837.289 46.394 41.979 15.9272 1.484
Local Peer EBOS GROUP ASX 3,281.589 23.831 21.542 2.5543 3.449
Local Peer NANOSONICS LIMITED ASX 2,170.361 159.558 177.782 18.4608 -
Local Peer MCP INCOME OPPORTUNITIES TRUST ASX 544.858 - - -381.6327 -
Local Peer MEDICAL DEVELOPMENT INTL ASX 528.269 508.850 460.968 11.8942 0.496
Local Peer VOLPARA HEALTH TECHNOLOGIES LTD ASX 346.412 - - 6.8426 -
Local Peer ATOMO DIAGNOSTICS LIMITED ASX 176.740 - - - -
Local Peer RESAPP HEALTH LIMITED ASX 121.295 - - 25.3846 -
Local Peer CYCLOPHARM LIMITED ASX 118.888 - - 5.1230 0.658
Local Peer SOMNOMED LIMITED ASX 125.338 - - 6.2372 -
Local Peer COMPUMEDICS ASX 90.353 22.497 26.843 3.2797 -
Other Local Peers SDI LTD (ASX), EMVISION MEDICAL DEVICES LTD (ASX), IMPEDIMED LIMITED (ASX), RESONANCE HEALTH LTD (ASX), ELLEX MEDICAL LASERS LTD (ASX), MICRO-X LTD (ASX), DIMERIX LTD (ASX), OVENTUS MEDICAL LTD (ASX), RESPIRI LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), IMPRESSION HEALTHCARE LIMITED (ASX), LBT INNOVATIONS LTD (ASX), USCOM LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), CARDIEX LTD (ASX), OPTISCAN IMAGING (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), ADHERIUM LIMITED (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), METALICITY LIMITED (ASX), ANALYTICA (ASX), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Global Peer ABBOTT LABORATORIES NYSE 163,830.887 44.689 46.293 5.4216 1.420
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 138,268.396 37.410 37.686 4.8415 0.219
Global Peer MEDTRONIC PLC NYSE 130,419.057 27.233 27.233 2.5705 2.221
Global Peer DANAHER CORP NYSE 118,044.059 47.430 43.129 4.0075 0.401
Global Peer STRYKER CORP NYSE 74,362.127 35.700 34.363 5.6700 1.075
Global Peer BECTON DICKINSON & CO NYSE 70,851.210 65.482 77.858 3.3821 1.183
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,616.283 49.022 48.775 7.9486 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 52,531.599 11.177 12.254 3.8055 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 46,369.457 44.292 41.857 11.8863 -
Global Peer BAXTER INTERNATIONAL INC NYSE 46,293.899 46.248 45.342 6.0130 0.929
Other Global Peers KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), DEXCOM INC (NASDAQ), ALCON AG (NYSE), IDEXX LABORATORIES INC (NASDAQ), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), BIO RAD LABORATORIES INC (NYSE), STERIS PLC (NYSE), HOLOGIC INC (NASDAQ), MASIMO CORPORATION (NASDAQ), INSULET CORPORATION (NASDAQ), WATERS CORP (NYSE), PERKINELMER INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), Top Glove (SGX), DENTSPLY SIRONA INC (NASDAQ), ABIOMED INC (NASDAQ), QIAGEN NV (NYSE), HARTA (Bursa), TOPGLOV (Bursa), WEIGAO GROUP (HKEx), QUIDEL CORP (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), PENUMBRA INC (NYSE), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), MICROPORT (HKEx), TANDEM DIABETES CARE INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEVRO CORP (NYSE), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), NEOGEN CORP (NASDAQ), AK MEDICAL (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), VENUS MEDTECH-B (HKEx), LIVANOVA PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), SUPERMX (Bursa), INSPIRE MEDICAL SYSTEMS INC (NYSE), PEIJIA-B (HKEx), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), STAAR SURGICAL CO (NASDAQ), GLAUKOS CORPORATION (NYSE), BIOTELEMETRY INC (NASDAQ), CAREDX INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), AVANOS MEDICAL INC (NYSE), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), KDL MEDICAL (HKEx), ATRION CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), INMODE LTD (NASDAQ), CERUS CORP (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), LIFETECH SCI (HKEx), ORASURE TECHNOLOGIES INC (NASDAQ), CRYOLIFE INC (NYSE), INOGEN INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), HESKA CORP (NASDAQ), CIRC (HKEx), NATUS MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), ZYNEX INC (NASDAQ), VAPOTHERM INC (NYSE), QUOTIENT LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), SI BONE INC (NASDAQ), SURMODICS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ANTARES PHARMA INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), AXOGEN INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), YESTAR HEALTH (HKEx), TRANSMEDICS GROUP INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), STEREOTAXIS INC (NYSE American), SEASPINE HOLDINGS CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), IRADIMED CORP (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CORMEDIX INC (NYSE American), PW MEDTECH (HKEx), VIEWRAY INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), CUTERA INC (NASDAQ), MISONIX INC (NASDAQ), INVACARE CORP (NYSE), GOLDEN MEDITECH (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), PROFOUND MED CORP (NASDAQ), DERMTECH INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), SIENTRA INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), ALPHA PRO TECH (NYSE American), SOLITON INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), MODERN DENTAL (HKEx), FONAR CORP (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), TELA BIO INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), INTRICOM CORP (NASDAQ), ELECTROMED INC (NYSE American), Medtecs Intl (SGX), BELLEROPHON THERAPEUTICS INC (NASDAQ), UG Healthcare (SGX), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), ONCOCYTE CORP (NYSE American), VOLITIONRX LIMITED (NYSE American), CELSION CORPORATION (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), Biolidics (SGX), ENLIVEX THERAPEUTICS LTD (NASDAQ), BIOMERICA INC (NASDAQ), NEPHROS INC (NASDAQ), LKL (Bursa), CONFORMIS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), YUNNAN ENERGY (HKEx), CLEARPOINT NEURO INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), VINCENT MED (HKEx), DAXOR CORP (NYSE American), ZOSANO PHARMA CORP (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), KELFRED (HKEx), THERMOGENESIS HOLDINGS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), ELECTROCORE INC (NASDAQ), NEURONETICS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), NEOVASC INC (NASDAQ), NEUROTROPE INC (NASDAQ), IMMUCELL CORP (NASDAQ), Yunnan Energy (SGX), IRIDEX CORP (NASDAQ), DARIOHEALTH CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), REWALK ROBOTICS LTD (NASDAQ), NANOVIBRONIX INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), LIFE HEALTHCARE (HKEx), RA MEDICAL SYSTEMS INC (NYSE), TITAN MEDICAL INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), CHECK-CAP LTD (NASDAQ), ENDOLOGIX INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), BIOLASE INC (NASDAQ), CYANOTECH CORP (NASDAQ), Annica (SGX), AVINGER INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), DYNATRONICS CORP (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), CANCER GENETICS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), INSPIREMD INC (NYSE American), HUAKANG BIOMED (HKEx), DIGIRAD CORP (NASDAQ), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.001
-5.56 %
10 Days --0.004
-19.05 %
20 Days --0.011
-39.29 %
Medium Term Return 3 Months --0.004
-19.05 %
6 Months --0.009
-34.62 %
1 Year --0.045
-72.58 %
Long Term Return 2 Years --0.099
-85.34 %
3 Years --0.286
-94.39 %
5 Years --0.247
-93.56 %
Annualised Return Annualised --
-42.22 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.008 - 0.062 Change From 1 Year Low +0.009 % Change From 1 Year Low (%) +112.50
Change From 1 Year High -0.045 % Change From 1 Year High (%) -72.58
2 Years Range 0.008 - 0.130 Change From 2 Years Low +0.009 % Change From 2 Years Low (%) +112.50
Change From 2 Years High -0.113 % Change From 2 Years High (%) -86.92
5 Years Range 0.008 - 0.573 Change From 5 Years Low +0.009 % Change From 5 Years Low (%) +112.50
Change From 5 Years High -0.556 % Change From 5 Years High (%) -97.03
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

dorsaVi Ltd. is a biotechnology company, which focuses on developing motion analysis device technologies for use in clinical practice, elite sports, and occupational health and safety. Its products include ViSafe, ViMove and ViPerform. The firm operates through the following segments: Clinical, Workplace, and Projects. dorsaVi was founded by Daniel Matthew Ronchi and Andrew James Ronchi on 18 February, 2008 and is headquartered in Melbourne East, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
03 Jun 2020 0.017 0.017 0.017 0.017 - -
02 Jun 2020 0.016 0.017 0.016 0.017 80,000 -
01 Jun 2020 0.018 0.019 0.017 0.017 547,159 -
29 May 2020 0.020 0.020 0.017 0.017 506,455 -
28 May 2020 0.022 0.022 0.018 0.018 1,355,939 -
27 May 2020 0.022 0.022 0.018 0.018 680,312 -
26 May 2020 0.023 0.023 0.023 0.023 - -
25 May 2020 0.021 0.023 0.021 0.023 70,282 -
22 May 2020 0.021 0.021 0.021 0.021 - -
21 May 2020 0.020 0.021 0.019 0.021 1,097,035 -
20 May 2020 0.025 0.025 0.021 0.021 204,589 -
19 May 2020 0.025 0.025 0.025 0.025 24,000 -
18 May 2020 0.025 0.025 0.025 0.025 - -
15 May 2020 0.024 0.027 0.024 0.025 836,276 -
14 May 2020 0.021 0.021 0.021 0.021 250,000 -
13 May 2020 0.020 0.021 0.020 0.021 129,000 -
12 May 2020 0.026 0.026 0.020 0.022 710,673 -
11 May 2020 0.026 0.026 0.026 0.026 - -
08 May 2020 0.030 0.030 0.026 0.026 864,807 -
07 May 2020 0.031 0.031 0.031 0.031 9,000 -
06 May 2020 0.027 0.033 0.027 0.028 765,035 -
05 May 2020 0.027 0.028 0.026 0.026 735,215 -
Summary
Current 2 Weeks
(21 May 2020 to 03 Jun 2020)
0.020 0.023 0.016 0.017 4,337,182 -
Previous 2 Weeks
(07 May 2020 to 20 May 2020)
0.031 0.031 0.016 0.021 3,028,345 -
4 Weeks from
(07 Apr 2020 to 06 May 2020)
0.010 0.023 0.010 0.028 10,075,919 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.